/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

U

Ulrich Julius

Technische Universität Dresden(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

293

Papers

5.6K

Citations

34

h-index

109

i10-index

Ulrich Julius is an academic researcher from Technische Universität Dresden. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Diabetes, Cardiovascular Risks, and Lipoproteins & Cancer, Lipids, and Metabolism. The author has an h-index of 34, co-authored 250 publications.

ORCID: 0000-0002-1584-5693

Research Topics

Lipoproteins and Cardiovascular Health Diabetes, Cardiovascular Risks, and Lipoproteins Cancer, Lipids, and Metabolism Lipid metabolism and disorders Pharmaceutical Economics and Policy

Papers by this author

works

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease

2013 · Circulation · 313 citations

https://doi.org/10.1161/circulationaha.113.002432

Josef Leebmann E. Roeseler Ulrich Julius Franz Heigl

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

2021 · The Lancet · 288 citations

https://doi.org/10.1016/s0140-6736(21)01122-3

Antonio J. Vallejo‐Vaz Christophe Stevens Alexander R.M. Lyons Kanika Dharmayat

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease

2016 · Arteriosclerosis Thrombosis and Vascular Biology · 211 citations

https://doi.org/10.1161/atvbaha.116.307983

E. Roeseler Ulrich Julius Franz Heigl Ralf Spitthoever

Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

2021 · The Lancet Diabetes & Endocrinology · 211 citations

https://doi.org/10.1016/s2213-8587(21)00046-2

Ioanna Gouni‐Berthold Veronica J. Alexander Qingqing Yang Eunju Hurh

Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern

2013 · Atherosclerosis Supplements · 58 citations

https://doi.org/10.1016/j.atherosclerosissup.2012.10.005

M. von Dryander Sabine Fischer Jens Passauer Gabriele Müller

Intraindividual Comparison of two Extracorporeal LDL Apheresis Methods: Lipidfiltration and HELP

2002 · The International Journal of Artificial Organs · 51 citations

https://doi.org/10.1177/039139880202501210

Ulrich Julius W Metzler Jens Pietzsch Thurid Faßbender

Research topics

topics

Lipoproteins and Cardiovascular Health

Diabetes, Cardiovascular Risks, and Lipoproteins

Cancer, Lipids, and Metabolism

Lipid metabolism and disorders

Pharmaceutical Economics and Policy

Chat about Author

Papers

Chat

Click to start Chat